Pharmacy and clinical research: the pharmaphorum podcastIn the latest episode of the pharmaphorum podcast, pharmaphorum’s web editor Catherine Longworth speaks to Gerald Finken, the founder Share XPharmacy and clinical research: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/pharmacy-clinical-research-rxe2/
physIQ licenses virtual trial tech to Janssen in multi-year dealBiosensor firm physIQ has licensed its technology to Johnson & Johnson’s Janssen pharma unit in a multi-year deal, Share XphysIQ licenses virtual trial tech to Janssen in multi-year dealhttps://pharmaphorum.com/news/physiq-licenses-virtual-trial-tech-to-janssen-in-multi-year-deal/
Virtual trials and the next generation of pharma clinical researchPreviously viewed as a ‘nice to have’ for the pharma industry, virtual trials were already moving from a Share XVirtual trials and the next generation of pharma clinical researchhttps://pharmaphorum.com/webinars/nihr-virtual-trials-pharma-research/
Introducing the new NIHR National Patient Recruitment CentresThe five new NIHR National Patient Recruitment Centres (NPRCs) are set to shape the future of commercial clinical Share XIntroducing the new NIHR National Patient Recruitment Centreshttps://pharmaphorum.com/webinars/nihr-national-patient-recruitment-centres/
Certara adds to its COVID-19 toolkit with virtual trials moduleDrugmakers have been working with data specialist Certara on a new tool that they hope could speed up Share XCertara adds to its COVID-19 toolkit with virtual trials modulehttps://pharmaphorum.com/news/certara-adds-to-its-covid-19-toolkit-with-virtual-trials-module/
Decentralised trials – aided by tech – could boost clinical researchBringing clinical trials to patients – rather than the reverse – could be the key to improving recruitment Share XDecentralised trials – aided by tech – could boost clinical researchhttps://pharmaphorum.com/news/decentralised-trials-aided-by-tech-could-boost-clinical-research/
COVID-19 driving adoption of virtual trialsA survey of clinical research professionals has found an acceleration in the adoption of virtual studies during the Share XCOVID-19 driving adoption of virtual trialshttps://pharmaphorum.com/news/covid-19-driving-adoption-of-virtual-trials/
COVID-19 could cause surge in virtual trials, says Vertex expertThe COVID-19 crisis is causing a surge in interest in ‘virtual trials’ where the bulk of the data Share XCOVID-19 could cause surge in virtual trials, says Vertex experthttps://pharmaphorum.com/news/covid-19-could-cause-surge-in-virtual-trials-says-vertex-expert/
Virtual trials take centre stage during COVID-19We speak to Bruce Hellman, CEO of uMotif, the patient-centric data capture platform specialists, to find out how Share XVirtual trials take centre stage during COVID-19https://pharmaphorum.com/r-d/views-analysis-r-d/virtual-trials-take-centre-stage-during-covid-19/
